Showing results (641-650 of 1,153) with videos related to
Sort By:
Pageof 116
Cancer Biology & Therapy|January 17, 2004
Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitizationFrank Tacke, Frank C Marini, Shourong Zhao, et al.Hepatology (Baltimore, Md.)|June 26, 2009
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosisKarlin Raja Karlmark, Ralf Weiskirchen, Henning W Zimmermann, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 27, 2018
CXCR6 protects from inflammation and fibrosis in NEMOLPC-KO miceAnke Liepelt, Alexander Wehr, Marlene Kohlhepp, et al.Scientific Reports|July 28, 2023
Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinomaIsabella Lurje, Nadine Therese Gaisa, Edgar Dahl, et al.Clinical and Molecular Hepatology|September 1, 2025
Predictive Machine Learning Model in ICU Patients with Acute-on-Chronic Liver Failure and Two or More Organ FailuresYee Hui Yeo, Mengyi Zhang, Martin S McCoy, et al.Gut|April 11, 2026
Tryptophan depletion generates hyper-reactive portal neutrophils in alcoholic liver diseaseSara Reinartz Groba, Mathis Richter, Dennis Schwarz, et al.Frontiers in Immunology|August 1, 2020
The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver DiseaseRobert Schierwagen, Frank E Uschner, Cristina Ortiz, et al.Journal of Hepatocellular Carcinoma|December 25, 2023
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver TransplantationThi Phuong Thao Hoang, Philipp Schindler, Nikolaus Börner, et al.Frontiers in Molecular Biosciences|September 13, 2021
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic SteatohepatitisSandra Torres, Maximilian J Brol, Fernando Magdaleno, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2020
Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunctionFrank E Uschner, Kathleen Glückert, Rafael Paternostro, et al.Pageof 116